Potent T cell agonism mediated by a very rapid TCR/pMHG interaction

European Journal of Immunology

Volumn 37, Issue 3, 2007, Pages 798-806

  Boulter, Jonathan M ^a   Schmitz, Nicole ^b   Sewell, Andrew K ^a   Godkin, Andrew J ^a   Bachmann, Martin F ^b   Gallimore, Awen M ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

Biophysics; Protein protein interactions; TCR

Indexed keywords

GLYCOPROTEIN GP 33; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; GLYCOPROTEIN; GLYCOPROTEIN PEPTIDE 33 41, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; GLYCOPROTEIN PEPTIDE 33-41, LYMPHOCYTIC CHORIOMENINGITIS VIRUS; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B); LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; PEPTIDE FRAGMENT; VIRUS ANTIGEN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; BINDING KINETICS; CELLULAR IMMUNITY; COMPLEX FORMATION; CONTROLLED STUDY; HALF LIFE TIME; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE; T LYMPHOCYTE ACTIVATION; TEMPERATURE MEASUREMENT; TRANSGENIC MOUSE; TUMOR REJECTION; VIRUS IMMUNITY; ANIMAL; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; ANTIGENS, VIRAL; GLYCOPROTEINS; H-2 ANTIGENS; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 34147094622     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636743     Document Type: Article

References (30)

1. Rudolph, M. G., Luz, J. G. and Wilson, I. A., Structural and thermodynamic correlates of T cell signaling. Annu. Rev. Biophys. Biomol. Struct. 2002. 31: 121-149.
2. Palmer, E., Negative selection - clearing out the bad apples from the T-cell repertoire. Nat. Rev. Immunol. 2003. 3: 383-391.
3. Jameson, S. C., T cell homeostasis: Keeping useful T cells alive and live T cells useful. Semin. Immunol. 2005. 17: 231-237.
4. Bachmann, M. F., Oxenius, A., Speiser, D. E., Mariathasan, S., Hengartner, H., Zinkernagel, R. M. and Ohashi, P. S., Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/ partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 1997. 27: 2195-2203.
5. Kalergis, A. M., Boucheron, N., Doucey, M. A., Palmieri, E., Goyarts, E. C., Vegh, Z., Luescher, I. F. and Nathenson, S. G., Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2001. 2: 229-234.
6. van der Merwe, P. A., The TCR triggering puzzle. Immunity 2001. 14: 665-668.
7. Valitutti, S., Muller, S., Cella, M., Padovan, E. and Lanzavecchia, A., Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995. 375: 148-151.
8. Krogsgaard, M., Prado, N., Adams, E. J., He, X. L., Chow, D. C., Wilson, D. B., Garcia, K. C. and Davis, M. M., Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. Mol. Cell 2003. 12: 1367-1378.
9. Holmberg, K., Mariathasan, S., Ohteki, T., Ohashi, P. S. and Gascoigne, N. R., TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR. J. Immunol. 2003. 171: 2427-2434.
10. Weidt, G., Deppert, W., Utermohlen, O., Heukeshoven, J. and Lehmann-Grube, F., Emergence of virus escape mutants after immunization with epitope vaccine. J. Virol. 1995. 69: 7147-7151.
11. Gronski, M. A., Boulter, J. M., Moskophidis, D., Nguyen, L. T., Holmberg, K., Elford, A. R., Deenick, E. K. et al., TCR affinity and negative regulation limit autoimmunity. Nat. Med. 2004. 10: 1234-1239.
12. Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D. et al., Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy. J. Exp. Med. 1997 186: 645-653.
13. Saibil, S. D., Ohteki, T., White, F. M., Luscher, M., Zakarian, A., Elford, A., Shabanowitz, J. et al., Weak agonist self-peptides promote selection and tuning of virus-specific T cells. Eur. J. Immunol. 2003. 33: 685-696.
14. Sebzda, E., Kundig, T. M., Thomson, C. T., Aoki, K., Mak, S. Y., Mayer, J. P., Zamborelli, T. et al., Mature T cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 1996. 183: 1093-1104.
15. Boulter, J. M., Glick, M., Todorov, P. T., Baston, E., Sami, M., Rizkallah, P. and Jakobsen, B. K., Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein Eng. 2003. 16: 707-711.
16. Chen, J. L., Stewart-Jones, G., Rossi, G., Lissin, N. M., Wooldridge, L., Choi, E. M., Held, G. et al., Structural and kinetic basis for heightened immunogenicity of T cell vaccines. J. Exp. Med. 2005. 201: 1243-1255.
17. Davis, M. M., Boniface, J. J., Reich, Z., Lyons, D., Hampl, J., Arden, B. and Chien, Y., Ligand recognition by alpha beta T cell receptors. Annu. Rev. Immunol. 1998. 16: 523-544.
18. Tissot, A. C., Ciatto, C., Mittl, P. R., Grutter, M. G. and Pluckthun, A., Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex. J. Mol. Biol. 2000. 302: 873-885.
19. Pircher, H., Moskophidis, D., Rohrer, U., Burki, K., Hengartner, H. and Zinkernagel, R. M., Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 1990. 346: 629-633.
20. Willcox, B. E., Gao, G. F., Wyer, J. R., Ladbury, J. E., Bell, J. L, Jakobsen, B. K. and van der Merwe, P. A., TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 1999. 10: 357-365.
21. Ely, L. K., Beddoe, T., Clements, C. S., Matthews, J. M., Purcell, A. W., Kjer-Nielsen, L., McCluskey, J. and Rossjohn, J., Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction. Proc. Natl. Acad. Sci. USA 2006. 103: 6641-6646.
22. Boniface, J. J., Reich, Z., Lyons, D. S. and Davis, M. M., Thermodynamics of T cell receptor binding to peptide-MHC: Evidence for a general mechanism of molecular scanning. Proc. Natl. Acad. Sci. USA 1999. 96: 11446-11451.
23. van der Merwe, P. A. and Davis, S. J., Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 2003. 21: 659-684.
24. Schamel, W. W., Arechaga, I., Risueno, R. M., van Santen, H. M., Cabezas, P., Risco, C., Valpuesta, J. M. and Alarcon, B., Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response. J. Exp. Med. 2005. 202: 493-503.
25. Yachi, P. P., Ampudia, J., Zal, T. and Gascoigne, N. R., Altered peptide ligands induce delayed CD8-T cell receptor interaction - a role for CD8 in distinguishing antigen quality. Immunity 2006. 25: 203-211.
26. Schirle, M., Keilholz, W., Weber, B., Gouttefangeas, C., Dumurese, T., Becker, H. D., Stevanovic, S. and Rammensee, H. G., Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach. Eur. J. Immunol. 2000. 30: 2216-2225.
27. Li, Y., Moysey, R., Molloy, P. E., Vuidepot, A. L., Mahon, T., Baston, E., Dunn, S. et al., Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nat. Biotechnol. 2005. 23: 349-354.
28. Schumacher, T. N., Heemels, M. T., Neefjes, J. J., Kast, W. M., Melief, C. J. and Ploegh, H. L., Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 1990. 62: 563-567.
29. Garboczi, D. N., Hung, D. T. and Wiley, D. C., HLA-A2-peptide complexes: Refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 1992. 89: 3429-3433.
30. O'Callaghan, C. A., Byford, M. F., Wyer, J. R., Willcox, B. E., Jakobsen, B. K., McMichael, A. J. and Bell, J. I., BirA enzyme: Production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Anal. Biochem. 1999. 266: 9-15.